Our Current Specialities:

Vascular clinical trials Vascular
Ophthalmology  clinical trials Ophthalmology
Family Medicine clinical trials Family Medicine
Orthopaedic clinical trials Orthopaedics
Clinical trials for ENT Ear Nose and Throat medications ENT
Clinical trials for Vaccine Trials Vaccine Trials 
Chronic pain, healthcare, patient, treatment Chronic Pain 
Cardiology, device, fetal, healthcare, medical, monitor Medical Devices
Healthy Volunteer Trials Healthy Volunteer Trials

About Clinical Trials New Zealand

Clinical Trials New Zealand Ltd (formerly Waikato Clinical Research 2008 Ltd) is a well established clinical trials unit which was founded in 1978 by Dr Brown, a USA Clinical Trials Investigator. The unit has performed a wide range of studies from Phase II to post marketing studies including post operative medical device studies and numerous pharmacokinetic studies. 

Clinical Trials New Zealand (CTNZ) has an excellent and well known international reputation for providing high quality data. The unit was instrumental in the development programme for Ketorolac (Toradol), and studies undertaken by CTNZ have had a significant effect on the understanding and management of post operative pain.

Over many years CTNZ has worked with US, other international pharmaceutical companies and clinical research organisations. We have access to CROs, independent monitors who have worked with CTNZ for some time.

As CTNZ is an independent entity, our processes ensure a quick start-up time for the sponsor, ethical approval within 24 to 30 days of submission and fast recruitment with realistic time frames.

This dedicated New Zealand research site is based at Waikato Hospital, and we conduct trials at both Waikato and Braemar Hospitals. Braemar is a leading private hospital adjacent to Waikato Hospital, a 850 bed hospital with specialist services within a catchment population area of 800,000.

The site has extensive experience with in-patient and out-patient trials (notably post-operative pain), excellent relationships exist with anaesthetists, orthopaedic and general surgeons providing sponsor access to peri, intra and post-operative patients from a number of therapeutic areas.

Positive FDA Audit

Clinical Trials New Zealand has successfully passed an FDA audit on a 300 patient acute post-operative pain trial.


The location of Hamilton has numerous convenient benefits in clinical trials:

  • Accessibility. The hub of the North Island, Hamilton is less than 1.5 hours drive from Auckland International Airport.
  • Safety. Hamilton is known as one of the safest cities in New Zealand.
  • First class public and private healthcare.
  • Specialists with international standards.


Since its beginnings in 1978, thousands of people have taken part in carefully designed studies to help ascertain the effectiveness and safety of new compounds.

  • A world-class track record in clinical trials.
  • Researchers and directors with international standing and close networks in their fields of expertise.
  • Dedicated team with a wealth of medical/nursing training and experience.
  • CTNZ has completed and participated in (and can co-ordinate) multiple single centre and multi-centre trials.


We are market leaders in Analgesic Clinical Trials. With over 30 years of experience, leading medical staff and our hospitals of world class facilities, we can offer fast and efficiently run clinical trials in a first world environment.

We pride ourselves in providing market trials with credible results that are reflective of the population of a modern society. Top quality is our benchmark and on this we have built up a solid market reputation for delivering a total trial package that represents the best market value.

Trial feasibility can be assessed in a timely manner with generally no cost to the sponsor.

A full range of regulatory and independent monitoring services is available if required. The New Zealand regulatory ;environment allows for regulatory approval and IEC/IRB approvals to run in parallel. IRB/IEC approvals are generally received within 4 weeks of submission.


Clinical trials conducted by CTNZ have been presented at international meetings in the USA, Europe, and Australasia.